HILLSBORO, Ore., Aug. 04, 2016 (GLOBE NEWSWIRE) -- FEI Company (Nasdaq:FEIC) today reported results for the second quarter of 2016. Second quarter revenue of $259 million was up 16% compared with $224 million for the second quarter of 2015. The company’s backlog of orders at the end of the second quarter of 2016 was $651 million compared with $541 million at the end of the second quarter of 2015. Bookings for the second quarter of 2016 were $259 million, resulting in a book-to-bill ratio of 1.0-to-1.
Diluted earnings per share computed on the basis of accounting principles generally accepted in the United States (GAAP) were $0.60 for the second quarter of 2016, compared with $0.89 in the second quarter of 2015. Net income for the quarter was $25 million compared with $37 million in the second quarter of 2015. Included in second quarter results were transaction costs related to the pending merger with Thermo Fisher Scientific Inc. and purchase accounting adjustments and integration costs related to the December 2015 acquisition of DCG Systems, Inc. These costs totaled $13 million, or $0.32 per share, net of taxes.
Gross margin for the second quarter was 48.8%, compared with 50.0% for the second quarter of 2015. Operating margin was 12.5% for the second quarter of 2016 compared to 20.5% for the second quarter of 2015.
Outlook and Investor Conference Call
Given the pending merger with Thermo Fisher Scientific Inc., the company will no longer provide a forward outlook and will not host a quarterly investor conference call.
About FEI:
FEI Company (Nasdaq:FEIC) designs, manufactures and supports a broad range of high-performance microscopy workflow solutions that provide images and answers at the micro-, nano- and picometer scales. Its innovation and leadership enable customers in industry and science to increase productivity and make breakthrough discoveries. Headquartered in Hillsboro, Ore., USA, FEI has over 3,000 employees and sales and service operations in more than 50 countries around the world. More information can be found at: www.fei.com.
FEI Company and Subsidiaries | ||||||||
Consolidated Balance Sheets | ||||||||
(In thousands) | ||||||||
(Unaudited) | ||||||||
July 3, 2016 | December 31, 2015 | |||||||
Assets | ||||||||
Current Assets: | ||||||||
Cash and cash equivalents | $ | 317,345 | $ | 300,911 | ||||
Restricted cash | 8,330 | 19,119 | ||||||
Receivables, net | 233,627 | 213,128 | ||||||
Inventories, net | 200,304 | 170,513 | ||||||
Deferred tax assets | — | 10,566 | ||||||
Other current assets | 69,612 | 33,614 | ||||||
Total current assets | 829,218 | 747,851 | ||||||
Long-term investments in marketable securities | 9,221 | 8,677 | ||||||
Long-term restricted cash | 16,481 | 22,113 | ||||||
Property plant and equipment, net | 164,521 | 155,608 | ||||||
Intangible assets, net | 60,777 | 35,943 | ||||||
Goodwill | 257,281 | 145,607 | ||||||
Deferred tax assets | 18,125 | 6,719 | ||||||
Long-term inventories | 54,402 | 47,109 | ||||||
Other assets, net | 22,968 | 180,222 | ||||||
Total Assets | $ | 1,432,994 | $ | 1,349,849 | ||||
Liabilities and Shareholders’ Equity | ||||||||
Current Liabilities: | ||||||||
Accounts payable | $ | 53,141 | $ | 58,708 | ||||
Accrued payroll liabilities | 40,131 | 38,643 | ||||||
Accrued warranty reserves | 15,796 | 14,107 | ||||||
Deferred revenue | 115,076 | 101,155 | ||||||
Income taxes payable | 10,290 | 12,124 | ||||||
Accrued restructuring and reorganization | 432 | 655 | ||||||
Other current liabilities | 61,434 | 52,630 | ||||||
Total current liabilities | 296,300 | 278,022 | ||||||
Long-term deferred revenue | 46,397 | 44,745 | ||||||
Other liabilities | 47,404 | 37,006 | ||||||
Shareholders’ Equity: | ||||||||
Preferred stock - 500 shares authorized; none issued and outstanding | — | — | ||||||
Common stock - 70,000 shares authorized; 41,016 and 40,855 shares issued and outstanding, no par value | 547,901 | 533,062 | ||||||
Retained earnings | 560,757 | 538,053 | ||||||
Accumulated other comprehensive loss | (65,765 | ) | (81,039 | ) | ||||
Total shareholders’ equity | 1,042,893 | 990,076 | ||||||
Total Liabilities and Shareholders’ Equity | $ | 1,432,994 | $ | 1,349,849 |
FEI Company and Subsidiaries | ||||||||||||||||
Consolidated Statements of Operations | ||||||||||||||||
(In thousands, except per share amounts) | ||||||||||||||||
(Unaudited) | ||||||||||||||||
Thirteen Weeks Ended | Twenty-Six Weeks Ended | |||||||||||||||
July 3, 2016 | June 28, 2015 | July 3, 2016 | June 28, 2015 | |||||||||||||
Net Sales: | ||||||||||||||||
Products | $ | 191,161 | $ | 163,585 | $ | 353,439 | $ | 327,644 | ||||||||
Service | 68,204 | 60,604 | 134,570 | 117,361 | ||||||||||||
Total net sales | 259,365 | 224,189 | 488,009 | 445,005 | ||||||||||||
Cost of Sales: | ||||||||||||||||
Products | 93,645 | 78,825 | 176,310 | 160,326 | ||||||||||||
Service | 39,275 | 33,259 | 77,982 | 67,303 | ||||||||||||
Total cost of sales | 132,920 | 112,084 | 254,292 | 227,629 | ||||||||||||
Gross profit | 126,445 | 112,105 | 233,717 | 217,376 | ||||||||||||
Operating Expenses: | ||||||||||||||||
Research and development | 29,968 | 23,128 | 57,613 | 46,450 | ||||||||||||
Selling, general and administrative | 64,117 | 43,093 | 113,356 | 88,915 | ||||||||||||
Restructuring and reorganization | — | (21 | ) | (102 | ) | (142 | ) | |||||||||
Total operating expenses | 94,085 | 66,200 | 170,867 | 135,223 | ||||||||||||
Operating Income | 32,360 | 45,905 | 62,850 | 82,153 | ||||||||||||
Other Expense, Net | (1,166 | ) | (590 | ) | (2,257 | ) | (1,557 | ) | ||||||||
Income Before Income Taxes | 31,194 | 45,315 | 60,593 | 80,596 | ||||||||||||
Income Tax Expense | 6,254 | 7,983 | 12,751 | 15,252 | ||||||||||||
Net Income | $ | 24,940 | $ | 37,332 | $ | 47,842 | $ | 65,344 | ||||||||
Basic Net Income Per Share | $ | 0.61 | $ | 0.90 | $ | 1.17 | $ | 1.57 | ||||||||
Diluted Net Income Per Share | $ | 0.60 | $ | 0.89 | $ | 1.16 | $ | 1.55 | ||||||||
Weighted Average Shares Outstanding: | ||||||||||||||||
Basic | 40,922 | 41,629 | 40,890 | 41,711 | ||||||||||||
Diluted | 41,389 | 42,044 | 41,304 | 42,142 |
FEI Company and Subsidiaries | ||||||||||||
Consolidated Statements of Operations | ||||||||||||
(Unaudited) | ||||||||||||
Thirteen Weeks Ended (1) | Twenty-Six Weeks Ended (1) | |||||||||||
July 3, 2016 | June 28, 2015 | July 3, 2016 | June 28, 2015 | |||||||||
Net Sales: | ||||||||||||
Products | 73.7 | % | 73.0 | % | 72.4 | % | 73.6 | % | ||||
Service | 26.3 | 27.0 | 27.6 | 26.4 | ||||||||
Total net sales | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | ||||
Cost of Sales: | ||||||||||||
Products | 36.1 | % | 35.2 | % | 36.1 | % | 36.0 | % | ||||
Service | 15.1 | 14.8 | 16.0 | 15.1 | ||||||||
Total cost of sales | 51.2 | % | 50.0 | % | 52.1 | % | 51.2 | % | ||||
Gross Margin: | ||||||||||||
Products | 51.0 | % | 51.8 | % | 50.1 | % | 51.1 | % | ||||
Service | 42.4 | 45.1 | 42.1 | 42.7 | ||||||||
Gross margin | 48.8 | % | 50.0 | % | 47.9 | % | 48.8 | % | ||||
Operating Expenses: | ||||||||||||
Research and development | 11.6 | % | 10.3 | % | 11.8 | % | 10.4 | % | ||||
Selling, general and administrative | 24.7 | 19.2 | 23.2 | 20.0 | ||||||||
Restructuring and reorganization | — | — | — | — | ||||||||
Total operating expenses | 36.3 | % | 29.5 | % | 35.0 | % | 30.4 | % | ||||
Operating Income | 12.5 | % | 20.5 | % | 12.9 | % | 18.5 | % | ||||
Other Expense, Net | (0.4 | )% | (0.3 | )% | (0.5 | )% | (0.3 | )% | ||||
Income Before Income Taxes | 12.0 | % | 20.2 | % | 12.4 | % | 18.1 | % | ||||
Income Tax Expense | 2.4 | % | 3.6 | % | 2.6 | % | 3.4 | % | ||||
Net Income | 9.6 | % | 16.7 | % | 9.8 | % | 14.7 | % | ||||
(1) Percentages may not add due to rounding.
FEI Company and Subsidiaries | ||||||||||||||||
Consolidated Summary of Cash Flows | ||||||||||||||||
(In thousands) | ||||||||||||||||
(Unaudited) | ||||||||||||||||
Thirteen Weeks Ended | Twenty-Six Weeks Ended | |||||||||||||||
July 3, 2016 | June 28, 2015 | July 3, 2016 | June 28, 2015 | |||||||||||||
Net Income | $ | 24,940 | $ | 37,332 | $ | 47,842 | $ | 65,344 | ||||||||
Depreciation | 6,888 | 6,082 | 13,681 | 12,063 | ||||||||||||
Amortization | 4,002 | 2,825 | 7,657 | 5,715 | ||||||||||||
Stock-based compensation | 6,030 | 4,545 | 11,869 | 10,494 | ||||||||||||
Other changes in working capital | (40,502 | ) | 15,076 | (51,550 | ) | (4,632 | ) | |||||||||
Net cash provided by operating activities | 1,358 | 65,860 | 29,499 | 88,984 | ||||||||||||
Acquisition of property, plant and equipment | (4,651 | ) | (2,677 | ) | (10,790 | ) | (7,869 | ) | ||||||||
Payments for acquisitions, net of cash acquired | — | — | — | (5,377 | ) | |||||||||||
Other investing activities | 12,985 | 22,376 | 17,014 | 17,059 | ||||||||||||
Net cash provided by investing activities | 8,334 | 19,699 | 6,224 | 3,813 | ||||||||||||
Dividends paid on common stock | (12,258 | ) | (10,427 | ) | (24,518 | ) | (20,877 | ) | ||||||||
Repurchases of common stock | — | (21,928 | ) | (943 | ) | (30,224 | ) | |||||||||
Other financing activities | 343 | 3,303 | 2,758 | 6,325 | ||||||||||||
Net cash used in financing activities | (11,915 | ) | (29,052 | ) | (22,703 | ) | (44,776 | ) | ||||||||
Effect of exchange rate changes | (8,508 | ) | 8,431 | 3,414 | (15,334 | ) | ||||||||||
(Decrease) increase in cash and cash equivalents | (10,731 | ) | 64,938 | $ | 16,434 | $ | 32,687 | |||||||||
Cash and Cash Equivalents: | ||||||||||||||||
Beginning of period | 328,076 | 268,256 | 300,911 | 300,507 | ||||||||||||
End of period | $ | 317,345 | $ | 333,194 | $ | 317,345 | $ | 333,194 | ||||||||
Supplemental Cash Flow Information: | ||||||||||||||||
Cash paid for income taxes, net | $ | 12,519 | $ | 4,655 | $ | 29,197 | $ | 10,597 | ||||||||
Increase in fixed assets related to transfers from inventories | 5,013 | 3,176 | 7,407 | 4,077 | ||||||||||||
Accrued purchases of plant and equipment | 791 | 443 | 791 | 443 | ||||||||||||
Dividends declared but not paid | 12,305 | 12,479 | 12,305 | 12,479 | ||||||||||||
Accrued repurchases of common stock | — | 1,271 | — | 1,271 |
FEI Company and Subsidiaries | ||||||||||||||||
Supplemental Data Table | ||||||||||||||||
($ in millions, except per share amounts) | ||||||||||||||||
(Unaudited) | ||||||||||||||||
Thirteen Weeks Ended | Twenty-Six Weeks Ended | |||||||||||||||
July 3, 2016 | June 28, 2015 | July 3, 2016 | June 28, 2015 | |||||||||||||
Income Statement Highlights: | ||||||||||||||||
Consolidated sales | $ | 259.4 | $ | 224.2 | $ | 488.0 | $ | 445.0 | ||||||||
Gross margin | 48.8 | % | 50.0 | % | 47.9 | % | 48.8 | % | ||||||||
Net income | $ | 24.9 | $ | 37.3 | $ | 47.8 | $ | 65.3 | ||||||||
Diluted net income per share | $ | 0.60 | $ | 0.89 | $ | 1.16 | $ | 1.55 | ||||||||
Sales and Bookings Highlights: | ||||||||||||||||
Sales by Segment | ||||||||||||||||
Industry Group | $ | 123.2 | $ | 119.6 | $ | 245.1 | $ | 231.5 | ||||||||
Science Group | 136.2 | 104.6 | 242.9 | 213.5 | ||||||||||||
Sales by Geography | ||||||||||||||||
USA & Canada | $ | 79.8 | $ | 76.4 | $ | 155.1 | $ | 141.4 | ||||||||
Europe | 68.0 | 56.8 | 129.1 | 111.3 | ||||||||||||
Asia-Pacific and Rest of World | 111.6 | 91.0 | 203.8 | 192.3 | ||||||||||||
Gross Margin by Segment | ||||||||||||||||
Industry Group | 52.8 | % | 54.1 | % | 51.1 | % | 52.4 | % | ||||||||
Science Group | 45.1 | 45.3 | 44.6 | 45.0 | ||||||||||||
Bookings and Backlog | ||||||||||||||||
Bookings - Total | $ | 258.9 | $ | 251.6 | $ | 531.0 | $ | 467.5 | ||||||||
Book-to-bill Ratio | 1.00 | 1.12 | 1.09 | 1.05 | ||||||||||||
Backlog - Total | $ | 651.1 | $ | 541.2 | $ | 651.1 | $ | 541.2 | ||||||||
Backlog - Service | 184.9 | 165.0 | 184.9 | 165.0 | ||||||||||||
Bookings by Segment | ||||||||||||||||
Industry Group | $ | 122.2 | $ | 112.7 | $ | 233.8 | $ | 249.8 | ||||||||
Science Group | 136.7 | 138.9 | 297.2 | 217.7 | ||||||||||||
Bookings by Geography | ||||||||||||||||
USA & Canada | $ | 87.1 | $ | 91.3 | $ | 209.3 | $ | 143.7 | ||||||||
Europe | 48.3 | 73.0 | 104.2 | 111.3 | ||||||||||||
Asia-Pacific and Rest of World | 123.5 | 87.3 | 217.5 | 212.5 | ||||||||||||
Balance Sheet and Other Highlights: | ||||||||||||||||
Cash, equivalents, investments, restricted cash | $ | 351.4 | $ | 512.7 | $ | 351.4 | $ | 512.7 | ||||||||
Days sales outstanding (DSO) | 82 | 86 | 82 | 86 | ||||||||||||
Days in inventory | 175 | 180 | 175 | 180 | ||||||||||||
Days in payables (DPO) | 36 | 61 | 36 | 61 | ||||||||||||
Cash Cycle (DSO + Days in Inventory - DPO) | 221 | 205 | 221 | 205 | ||||||||||||
Working capital | $ | 532.9 | $ | 537.7 | $ | 532.9 | $ | 537.7 | ||||||||
Headcount (permanent and temporary) | 3,125 | 2,826 | 3,125 | 2,826 | ||||||||||||
Euro average rate | 1.13 | 1.10 | 1.11 | 1.12 | ||||||||||||
Euro ending rate | 1.11 | 1.12 | 1.11 | 1.12 | ||||||||||||
Yen average rate | 108.10 | 121.01 | 112.11 | 119.97 | ||||||||||||
Yen ending rate | 102.65 | 123.71 | 102.65 | 123.71 |